RANI:NASDAQ, Rani Therapeutics Holdings, Inc.

Why RANI stock rose on November 18

Rani Therapeutics Holdings, Inc. rose 15.9% on Wednesday, November 18, 2026, on 1,199,600 shares, 2.2 times its average daily volume. No headline about RANI came out that day or the day before in the news feeds we follow, so the move may come from news we don't track, the sector or trading alone.

RANI stock overview

Rani Therapeutics Holdings, Inc. (RANI:NASDAQ) closed at $0.511 on November 20, 2026, down 11.97% on the day. The stock trades 69.8% below its 52-week high of $1.70 and 1.8% above its 52-week low of $0.502. Over the past year, it lost 69.2%. Rani Therapeutics Holdings, Inc. is part of the Health Care sector.

Key figures

Price
$0.511
Day change
-11.97%
Volume
457,417
Average volume
549,557
Market cap
59M+
52-week range
$0.502 – $1.70
50-day average
$0.685
200-day average
$0.880

Price action over the past year

In 252 trading sessions since November 20, 2025, RANI closed higher on 112 days (44%). Its best day was July 22, 2026 (+29.81%) and its worst was March 27, 2026 (-24.91%). The stock moved 10% or more in a single session 16 times. It opened at least 5% above the previous day's high 1 time.

Recent signals

RANI news

About Rani Therapeutics Holdings, Inc.

Rani Therapeutics Holdings Inc is a clinical stage biotherapeutics company advancing technologies to enable the development of orally administered biologics. It has developed the RaniPill capsule, proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing.

Similar stocks

Find more stocks like RANI with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.